ESC Premium Access

Clarifying the role for DPP-4 inhibitors in the treatment of patients with type 2 diabetes at risk of heart failure.

Presentation

About the speaker

Professor Darren Keith McGuire

University of Texas Southwestern Medical Center & Parkland Health and Hospital S, Dallas (United States of America)
18 presentations
0 follower

6 more presentations in this session

Opening remarks - Considerations for cardiologists: further insights into treatment options for patients with type 2 diabetes and cardiovascular disease.

Speaker: Professor S. Del Prato (Pisa, IT)

Thumbnail

Why control glycemia?

Speaker: Professor L. Leiter (Toronto, CA)

Thumbnail

DPP-4 inhibitors and SGLT2 inhibitors - A mechanism for the future?

Speaker: Associate Professor D. Cherney (Toronto, CA)

Thumbnail

Q&A - Considerations for cardiologists: further insights into treatment options for patients with type 2 diabetes and cardiovascular disease.

Speaker: Professor S. Del Prato (Pisa, IT)

Thumbnail

Clinical considerations - A perspective across specialties.

Speaker: Professor S. Del Prato (Pisa, IT) Professor D. McGuire (Dallas, US) Professor L. Leiter (Toronto, CA) Associate Professor D. Cherney (Toronto, CA)

Thumbnail

Access the full session

Considerations for cardiologists: further insights into treatment options for patients with type 2 diabetes and cardiovascular disease

Speakers: Professor D. McGuire, Professor S. Del Prato, Professor L. Leiter, Associate Professor D. Cherney, Professor S. Del Prato...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk